Wall Street Zen Upgrades Olin (NYSE:OLN) to "Sell"

Key Points

• Wall Street Zen upgraded Olin from “strong sell” to “sell,” but the overall analyst consensus remains “Reduce,” with a consensus price target of $20.07.
• Olin reported third-quarter EPS of $0.13 and revenue of $1.75 billion, missing broader analyst expectations of $0.15 EPS and $1.83 billion in revenue. Net income fell to $14.4 million from $42.8 million year over year.
• The stock opened at $17.56, well below its 200-day moving average of $22.28. Investors are also weighing approximately $2.8 billion in net debt, weaker fourth-quarter EBITDA guidance, and uncertainty around the Huntsman merger.

Olin (NYSE:OLN - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "strong sell" rating to a "sell" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other research analysts have also commented on the company. UBS Group lowered their price target on Olin from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Monday, October 5th. BMO Capital Markets reduced their price objective on shares of Olin from $30.00 to $25.00 and set a "market perform" rating for the company in a report on Monday, July 6th. KeyCorp started coverage on shares of Olin in a research report on Friday, September 11th. They issued an "overweight" rating and a $26.00 target price for the company. Barclays assumed coverage on shares of Olin in a research report on Monday, October 12th. They issued an "equal weight" rating and a $18.00 target price for the company. Finally, Wells Fargo & Company lowered their target price on shares of Olin from $20.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Thursday, October 1st. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and a consensus price target of $20.07.

Olin Price Performance

OLN opened at $17.56 on Friday. The stock's 50 day moving average price is $16.44 and its 200 day moving average price is $22.28. The company has a debt-to-equity ratio of 1.77, a quick ratio of 0.87 and a current ratio of 1.42. Olin has a 12 month low of $14.64 and a 12 month high of $30.46.

Olin (NYSE:OLN - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.02). Olin had a negative return on equity of 6.58% and a negative net margin of 2.49%. The business had revenue of $1.75 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter last year, the firm posted $0.37 EPS. The company's revenue was up 2.0% compared to the same quarter last year. On average, analysts anticipate that Olin will post -0.80 EPS for the current fiscal year.

Institutional Trading of Olin

A number of hedge funds and other institutional investors have recently modified their holdings of OLN. Dimensional Fund Advisors LP lifted its position in shares of Olin by 22.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,627,997 shares of the specialty chemicals company's stock valued at $167,311,000 after acquiring an additional 1,031,498 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of Olin by 2.0% during the 3rd quarter. Pzena Investment Management LLC now owns 3,966,952 shares of the specialty chemicals company's stock worth $61,488,000 after acquiring an additional 76,748 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Olin by 1.0% during the 1st quarter. Bank of New York Mellon Corp now owns 1,232,912 shares of the specialty chemicals company's stock worth $36,654,000 after acquiring an additional 12,290 shares in the last quarter. First Trust Advisors LP grew its holdings in shares of Olin by 80.8% in the 1st quarter. First Trust Advisors LP now owns 713,041 shares of the specialty chemicals company's stock worth $21,199,000 after acquiring an additional 318,588 shares during the last quarter. Finally, Amundi grew its holdings in shares of Olin by 337.2% in the 1st quarter. Amundi now owns 684,036 shares of the specialty chemicals company's stock worth $20,336,000 after acquiring an additional 527,586 shares during the last quarter. Institutional investors own 88.67% of the company's stock.

Key Stories Impacting Olin

Here are the key news stories impacting Olin this week:

• Positive Sentiment: Olin reported adjusted EBITDA of $191.4 million and said its merger with Huntsman remains targeted for completion in the first quarter of 2027. Management also cited substantial progress on integration planning, providing a potential longer-term catalyst. Olin Announces Third Quarter 2026 Results
• Positive Sentiment: Reported earnings of $0.13 per share exceeded some published estimates, including FactSet’s $0.11 forecast and Zacks’ $0.10 consensus. Winchester sales rose to $484.7 million from $439.6 million, while Epoxy sales increased to $412.2 million from $349.6 million. Olin Q3 Earnings Beat Estimates
• Neutral Sentiment: Third-quarter sales increased 2% year over year to $1.75 billion, but results varied significantly by segment: Chlor Alkali Products and Vinyls sales declined to $850.8 million, offset by growth in Epoxy and Winchester. Olin Reports Third-Quarter 2026 Net Income
• Negative Sentiment: Olin’s $0.13 EPS missed the broader consensus estimate of $0.15, while revenue fell short of the $1.83 billion forecast. Net income dropped to $14.4 million from $42.8 million a year earlier, and acquisition-related costs totaled $13.7 million. Olin Q3 Earnings Report
• Negative Sentiment: Fourth-quarter adjusted EBITDA guidance of $80 million to $100 million signals a sharp sequential slowdown. Investors are also weighing approximately $2.8 billion of net debt and continued uncertainty surrounding the timing and execution of the Huntsman transaction. Olin Q3 2026 Earnings Analysis

Olin Company Profile

Olin Corporation NYSE: OLN is a global manufacturer of chemicals and ammunition. The company operates through three primary businesses: Chlor Alkali Products and Vinyls, Epoxy, and Winchester.

Its Chlor Alkali Products and Vinyls business produces chlorine, caustic soda, hydrochloric acid, bleach products, hydrogen, chlorinated organic chemicals and other related materials used in industrial, water-treatment, construction and consumer applications. Olin's Epoxy business manufactures epoxy resins, intermediates and other specialty materials used in coatings, adhesives, composites, electronics and infrastructure-related applications.

Through its Winchester business, Olin produces and distributes sporting ammunition, reloading components, and small-caliber ammunition for law enforcement and military customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.